MS vs IVZ
By Alex · Tickerpine
Morgan Stanley vs Invesco Ltd., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MS | IVZ |
|---|---|---|
| Price | $190.65 | $28.92 |
| Market cap | $297.99B | $12.71B |
| P/E ratio | 15.1 | — |
| ROE | 18.04% | -0.58% |
| Profit margin | 25.63% | -1.10% |
| Revenue growth | 10.80% | 14.20% |
| Dividend yield | 2.41% | 2.97% |
| Beta | 1.22 | 1.65 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MS vs IVZ in plain English
- MS is the bigger company — about 23.4× the market cap of IVZ.
- MS earns a higher return on equity (18% vs -1%).
- IVZ is growing revenue faster (14% vs 11%).
- IVZ has the higher dividend yield (2.97% vs 2.41%).
How would $1,000 have done in each?
MS return calculator
See what $1,000 in Morgan Stanley would be worth today.
IVZ return calculator
See what $1,000 in Invesco Ltd. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.